SurgeryMEPONCT06480370
Optimization of Transcranial Motor Evoked Potentials in Supratentorial Surgeries
A study testing ISIS IOM System in people with Surgery, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.
Trial summary
This project aims to optimize the methodology to elicite transcranial motor evoked potentials in intraoperative neurophysiological monitoring of brain surgery. It includes accelerometer measurements and microscope video image to determine movement of the surgical field, making possible minimization of movement during… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Surgery
- What is being tested?
- ISIS IOM System
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 203 participants
- Where
- 1 siteSwitzerland
- Study dates
- 20 Feb 2025to Dec 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Informed consent signed by the subject
- The patient has a supra-tentorial lesion requiring surgery
- The patient is undergoing neurosurgery with the use of MEP monitoring during surgery to protect functional tissue* (During routine preparation for the surgery, patients are checked for any relative contraindications as listed in the user manual of the ISIS IOM System (see p. 11, chapter 2.2.4 of the user manual). Every relative contraindication must be weighed against the risk and benefits of the measurement signals which are routinely needed for the surgical intervention. There are no absolute contraindications for the ISIS IOM System.)
- The patient is older than 18 years
Who cannot join
- No need for MEP monitoring
- Vulnerable subjects (pregnant, impaired consciousness)
- People who do not want to participate in the study
- Emergency procedures in which no consent was obtained before the operation
- Multiple surgeries on the same patient
- Preoperative non-affected arm or leg motor deficit (MRC <5), that is to say, no motor deficit of the arm or leg ipsilateral to the surgery
Show all 9Show fewer
- Inhalational anesthesia
- Persisting neuromuscular blockade
- Impossibility to place the stimulating or recording electrodes in the appropriate site
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pablo Abel Alvarez Abut, MD contact
Switzerland1 site, 1 recruiting
- Recruiting
Dep. of Neurosurgery, Bern University Hospital
Bern, 3010
Kathleen Seidel, MD, +41316322409, kathleen.seidel@insel.ch
Pablo Abel Alvarez Abut, MD, pabloabel.alvarezabut@insel.ch
About this study
This project aims to optimize the methodology to elicite transcranial motor evoked potentials in intraoperative neurophysiological monitoring of brain surgery. It includes accelerometer measurements and microscope video image to determine movement of the surgical field, making possible minimization of movement during brain stimulation.
Read the detailed description
Background: During supratentorial brain surgery there is a risk of iatrogenic injury resulting in post-operative motor deficits. Intraoperative neurophysiological monitoring (IONM) can help surgeons avoid this outcome, while also expanding evidence of its prognostic and preventive benefit (1, 2). However, there are still pending issues, such as standardization of optimal methodologies for data acquisition and interpretation as well as technical improvement.
There are two main IONM strategies: mapping to localize nervous structures, and monitoring to provide real-time assessment of functional integrity (3). With respect to monitoring, muscle motor evoked potentials (MEPs) enable motor system assessment. They can be elicited by pulse train transcranial electric stimulation (TES) through scalp electrodes placed at standard 10-20 system sites (C1, C2, C3, C4, Cz-1cm, Cz+6cm), or at neuronavigation-guided scalp sites. The stimulation circuit consists of the user-selected anode and cathode sites chosen from the scalp electrodes (4). The stimulation parameters are user-selected pulse duration, interstimulus interval (ISI), number of pulses, and single train stimulation vs. double-train or multi-train facilitation. MEP threshold is the stimulation intensity required to elicit a certain number of MEPs with a predefined amplitude. The recording montage consists of user-selected recording electrode orientation and target muscles. Practitioner preferences for these technical aspects vary widely (5), and can influence monitoring efficacy.
During surgery, significant MEP deterioration from an earlier baseline indicates a warning based on various criteria such as amplitude reduction or threshold elevation (2). Warnings trigger rescue manoeuvres to recover MEPs. With reversible MEP deterioration (recovery to values above the warning level), a post-operative motor deficit might be prevented. Continuous real-time monitoring facilitates this favourable result by providing early warnings, and is therefore important. With irreversible MEP deterioration there is an increased risk of a motor deficit (1), and discontinuous intermittent monitoring may fail to help prevent this adverse outcome.
A major concern regarding TES MEPs is that the stimuli often produce movement of the surgical field, which entails the risk of the patient being harmed by surgical manoeuvres if they are not paused during the measurements (4). This can delay the surgical procedure and/or preclude real-time monitoring. Thus, there is a need to establish optimal TES MEP methodology that minimizes objectively assessed movement.
Objective: The hypothesis of this project is that MEP stimulation and recording paradigms can be optimized to minimize movement of the surgical field during supratentorial brain surgery. Consequently, the overall aim is to identify the most effective stimulation and recording techniques to maximize TES MEP performance by minimizing movement. The specific objectives are to determine:
- The best stimulation circuit to elicit MEPs with the lowest possible movement;
- The best stimulation parameters to elicit MEPs with the lowest possible movement;
- The best recording montages to obtain MEPs with the lowest possible stimulation threshold.
Methods: General methods: Adult patients undergoing routine brain surgery with IONM and giving informed consent will be eligible. Muscle MEP recordings will be performed from limbs ipsilateral to the operation side. Patients with preoperative ipsilateral motor impairment will be excluded. Movement and MEP threshold will be the primary endpoints. Movement will be assessed through one accelerometer on the forehead (with quantification through kinetic energy). For comparison (secondary endpoint), another accelerometer on the ipsilateral shoulder to the recording site will be used, as well as the subjective evaluation by the surgeon on an ordinal scale, through visualization of the surgical field. Additionally, we propose to quantify the magnitude of motion using post-processing of digital images from the surgical microscope.
Comparative analyses of movement and MEP thresholds will be performed by successively varying one of the variables and keeping the others at Inselspital standard. Videos of the surgical field will be recorded with the microscope for all the proposed experimental setups, to recover the images for the quantification of the movement.
The study will be divided into four different parts, each of them with different steps (outlined below). Consequently, each patient participates in a specific part and stepThis subdivision is necessary due to time constraints in the operating room, as it would not be feasible to perform all the different combinations on every patient.
Patients who have already been included in the study and require a redo surgery will also be eligible for inclusion in a different part or step of the study.
Threshold current will be defined as the minimum current to elicit MEP responses with an amplitude higher than 20 µV in at least 5 consecutive trials. The procedure will be to increase current until MEPs appear, then reduce current until they disappear, and then finely adjust current to the minimum for a consistent response.
Part 1: determination of the best stimulation circuit. Step 1 - comparison of 10-20 system stimulation circuits: Evaluation of 12 patients. Circuits of C1/C2, C3/C4, and C3 or C4/Cz-1cm for upper limb MEPs, and C1/C2, C3/C4, and Cz-1cm/Cz+6cm for lower limb MEPs. Acquisition of 12 MEPs per limb with each circuit.
Step 2 - comparison of the best Step 1 circuit to the neuronavigation-guided stimulation circuit: Evaluation of 16 patients. Acquisition of 22 upper limb MEPs with each circuit.
Part 2: determination of the best stimulation parameters. Step 1 - comparison of different pulse durations: Evaluation of 21 patients. Pulse duration of 100, 200, 350, 500, 650, 800, and 1000 µs. Acquisition of 21 upper limb MEPs with each pulse duration.
Step 2 - comparison of different ISIs: Evaluation of 30 patients (15 per limb). ISI of 1, 2, 3, 4, and 5 ms. Acquisition of 20 upper and lower limb MEPs with each ISI.
Step 3 - comparison of different numbers of pulses: Evaluation of 15 patients. Number of pulses of 3, 4, 5, 7, and 9. Acquisition of 20 upper limb MEPs with each number of pulses.
Step 4 - comparison of single train to double-train facilitation at different inter train intervals (ITIs): Evaluation of 21 patients. Single train, double train (2/7 and 4/4 pulses). ITI of 20, 85, and 150 ms. Acquisition of 21 upper limb MEPs with each paradigm.
Step 5 - comparison of single train to multi-train facilitation at different rates: Evaluation of 21 patients. Single train at rate of 0.5 Hz. Multi-train facilitation at rates of 1, 2, 3, 4, 5, and 6 Hz. Acquisition of 21 upper limb MEPs with each paradigm.
Part 3: determination of the best recording montages. Step 1 - comparison of recording electrode orientations: Evaluation of 12 patients. Recordings from extensor digitorum communis (EDC) and tibialis anterior (TA). Three recording orientations: 1) bipolar perpendicular to muscle fibres, 2) bipolar parallel to muscle fibres, and 3) referential to the distal muscle tendon. Determination of threshold* per orientation within each muscle.
Step 2 - determination of muscles of choice in distal upper limbs: Evaluation of 21 patients. Recordings from abductor pollicis brevis (APB), abductor digiti minimi (ADM), first dorsal interosseous, EDC, flexor carpi radialis (FCR), APB/ADM, and EDC/FCR. Determination of threshold* for all muscles.
Step 3 - determination of muscles of choice in distal lower limbs: Evaluation of 18 patients. Recordings from abductor hallucis (AH), extensor digitorum brevis (EDB), TA, soleus, AH/EDB, and TA/soleus. Determination of threshold* for all muscles.
Part 4: Evaluation of 16 patients. Comparison of best stimulation and recording methodology from the results of Parts 1 to 3 with the current standard in our department. Acquisition of 22 MEPs per limb by paradigm.
- Conditions
- Surgery
- Being tested
- ISIS IOM System
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ISIS IOM SystemDevice
Application of TES at different stimulation circuits, with different stimulation parameters and recording montages.
| Study group | Role | What they receive |
|---|---|---|
| Study Arm | Experimental | Application of TES at different stimulation circuits, with different stimulation parameters and recording montages. Receives: Device: ISIS IOM System |
What is being measured
The primary outcome is the main question the study is designed to answer.
threshold of stimulation and patient movement
threshold of stimulation and patient movement quantified by an accelerometer placed on the forehead of the patient
Measured: during surgery
Secondary outcomes (3)
patient movement
patient movement quantified by an accelerometer on the shoulder
Measured: during surgery
subjective evaluation of magnitude of motion
subjective evaluation by the surgeon of magnitude of motion using post-processing of digital images from the surgical microscope
Measured: end of surgery
quantification of magnitude
quantification of magnitude of motion using post-processing of digital images from the surgical microscope
Measured: end of surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jun 2024
- Study start20 Feb 2025
- Primary completion30 Jun 2028 (estimated)
- Study completionDec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for SurgeryStudies of the same condition, open and under way.
- More trials run by Insel Gruppe AG, University Hospital BernThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 203 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Seidel Kathleen, MD, Principal investigator, Department of Neurosurgery
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06480370
- Sponsor's protocol ID
- 2024-D0039
- Acronym
- MEPO
- Status last verified
- Apr 2026
- First submitted
- 24 Jun 2024
- Last updated
- 1 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Holdefer RN, Skinner SA. Commentary : The value of intraoperative neurophysiological monitoring: evidence, equipoise and outcomes. J Clin Monit Comput. 2017 Aug;31(4):657-664. doi: 10.1007/s10877-016-9910-0. Epub 2016 Aug 1.
PubMed 27481235Asimakidou E, Abut PA, Raabe A, Seidel K. Motor Evoked Potential Warning Criteria in Supratentorial Surgery: A Scoping Review. Cancers (Basel). 2021 Jun 4;13(11):2803. doi: 10.3390/cancers13112803.
PubMed 34199853Seidel K, Beck J, Stieglitz L, Schucht P, Raabe A. The warning-sign hierarchy between quantitative subcortical motor mapping and continuous motor evoked potential monitoring during resection of supratentorial brain tumors. J Neurosurg. 2013 Feb;118(2):287-96. doi: 10.3171/2012.10.JNS12895. Epub 2012 Nov 30.
PubMed 23198802Macdonald DB, Skinner S, Shils J, Yingling C; American Society of Neurophysiological Monitoring. Intraoperative motor evoked potential monitoring - a position statement by the American Society of Neurophysiological Monitoring. Clin Neurophysiol. 2013 Dec;124(12):2291-316. doi: 10.1016/j.clinph.2013.07.025. Epub 2013 Sep 18.
PubMed 24055297Dulfer SE, Gadella MC, Sahinovic MM, Lange F, Absalom AR, Groen RJM, Szelenyi A, Drost G. Stimulation parameters for motor evoked potentials during intraoperative spinal cord monitoring. A systematic review. Clin Neurophysiol. 2023 May;149:70-80. doi: 10.1016/j.clinph.2023.02.170. Epub 2023 Mar 4.
PubMed 36924672Fujii M, Maesawa S, Motomura K, Futamura M, Hayashi Y, Koba I, Wakabayashi T. Intraoperative subcortical mapping of a language-associated deep frontal tract connecting the superior frontal gyrus to Broca's area in the dominant hemisphere of patients with glioma. J Neurosurg. 2015 Jun;122(6):1390-6. doi: 10.3171/2014.10.JNS14945. Epub 2015 Mar 27.
PubMed 25816090Kapsalakis IZ, Kapsalaki EZ, Gotsis ED, Verganelakis D, Toulas P, Hadjigeorgiou G, Chung I, Fezoulidis I, Papadimitriou A, Robinson JS, Lee GP, Fountas KN. Preoperative evaluation with FMRI of patients with intracranial gliomas. Radiol Res Pract. 2012;2012:727810. doi: 10.1155/2012/727810. Epub 2012 Jul 12.
PubMed 22848821Moiyadi A, Velayutham P, Shetty P, Seidel K, Janu A, Madhugiri V, Singh VK, Patil A, John R. Combined Motor Evoked Potential Monitoring and Subcortical Dynamic Mapping in Motor Eloquent Tumors Allows Safer and Extended Resections. World Neurosurg. 2018 Dec;120:e259-e268. doi: 10.1016/j.wneu.2018.08.046. Epub 2018 Aug 21.
PubMed 30138733Raabe A, Beck J, Schucht P, Seidel K. Continuous dynamic mapping of the corticospinal tract during surgery of motor eloquent brain tumors: evaluation of a new method. J Neurosurg. 2014 May;120(5):1015-24. doi: 10.3171/2014.1.JNS13909. Epub 2014 Mar 14.
PubMed 24628613Schucht P, Seidel K, Beck J, Murek M, Jilch A, Wiest R, Fung C, Raabe A. Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome. Neurosurg Focus. 2014 Dec;37(6):E16. doi: 10.3171/2014.10.FOCUS14524.
PubMed 25434385
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Optimization of Transcranial Motor Evoked Potentials in Supratentorial Surgeries
- ClinicalTrials.gov ID
- NCT06480370
- Acronym / sponsor ID
- MEPO / 2024-D0039
- Conditions
- Surgery
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 203 participants (estimated)
- Lead sponsor
- Insel Gruppe AG, University Hospital BernUniversity, hospital or other
- Study start
- 20 Feb 2025 (actual)
- Primary completion
- 30 Jun 2028 (estimated)
- Study completion
- Dec 2028 (estimated)
- First posted
- 28 Jun 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project aims to optimize the methodology to elicite transcranial motor evoked potentials in intraoperative neurophysiological monitoring of brain surgery. It includes accelerometer measurements and microscope video image to determine movement of the surgical field, making possible minimization of movement during brain stimulation.
Detailed description
Background: During supratentorial brain surgery there is a risk of iatrogenic injury resulting in post-operative motor deficits. Intraoperative neurophysiological monitoring (IONM) can help surgeons avoid this outcome, while also expanding evidence of its prognostic and preventive benefit (1, 2). However, there are still pending issues, such as standardization of optimal methodologies for data acquisition and interpretation as well as technical improvement.
There are two main IONM strategies: mapping to localize nervous structures, and monitoring to provide real-time assessment of functional integrity (3). With respect to monitoring, muscle motor evoked potentials (MEPs) enable motor system assessment. They can be elicited by pulse train transcranial electric stimulation (TES) through scalp electrodes placed at standard 10-20 system sites (C1, C2, C3, C4, Cz-1cm, Cz+6cm), or at neuronavigation-guided scalp sites. The stimulation circuit consists of the user-selected anode and cathode sites chosen from the scalp electrodes (4). The stimulation parameters are user-selected pulse duration, interstimulus interval (ISI), number of pulses, and single train stimulation vs. double-train or multi-train facilitation. MEP threshold is the stimulation intensity required to elicit a certain number of MEPs with a predefined amplitude. The recording montage consists of user-selected recording electrode orientation and target muscles. Practitioner preferences for these technical aspects vary widely (5), and can influence monitoring efficacy.
During surgery, significant MEP deterioration from an earlier baseline indicates a warning based on various criteria such as amplitude reduction or threshold elevation (2). Warnings trigger rescue manoeuvres to recover MEPs. With reversible MEP deterioration (recovery to values above the warning level), a post-operative motor deficit might be prevented. Continuous real-time monitoring facilitates this favourable result by providing early warnings, and is therefore important. With irreversible MEP deterioration there is an increased risk of a motor deficit (1), and discontinuous intermittent monitoring may fail to help prevent this adverse outcome.
A major concern regarding TES MEPs is that the stimuli often produce movement of the surgical field, which entails the risk of the patient being harmed by surgical manoeuvres if they are not paused during the measurements (4). This can delay the surgical procedure and/or preclude real-time monitoring. Thus, there is a need to establish optimal TES MEP methodology that minimizes objectively assessed movement.
Objective: The hypothesis of this project is that MEP stimulation and recording paradigms can be optimized to minimize movement of the surgical field during supratentorial brain surgery. Consequently, the overall aim is to identify the most effective stimulation and recording techniques to maximize TES MEP performance by minimizing movement. The specific objectives are to determine:
- The best stimulation circuit to elicit MEPs with the lowest possible movement;
- The best stimulation parameters to elicit MEPs with the lowest possible movement;
- The best recording montages to obtain MEPs with the lowest possible stimulation threshold.
Methods: General methods: Adult patients undergoing routine brain surgery with IONM and giving informed consent will be eligible. Muscle MEP recordings will be performed from limbs ipsilateral to the operation side. Patients with preoperative ipsilateral motor impairment will be excluded. Movement and MEP threshold will be the primary endpoints. Movement will be assessed through one accelerometer on the forehead (with quantification through kinetic energy). For comparison (secondary endpoint), another accelerometer on the ipsilateral shoulder to the recording site will be used, as well as the subjective evaluation by the surgeon on an ordinal scale, through visualization of the surgical field. Additionally, we propose to quantify the magnitude of motion using post-processing of digital images from the surgical microscope.
Comparative analyses of movement and MEP thresholds will be performed by successively varying one of the variables and keeping the others at Inselspital standard. Videos of the surgical field will be recorded with the microscope for all the proposed experimental setups, to recover the images for the quantification of the movement.
The study will be divided into four different parts, each of them with different steps (outlined below). Consequently, each patient participates in a specific part and stepThis subdivision is necessary due to time constraints in the operating room, as it would not be feasible to perform all the different combinations on every patient.
Patients who have already been included in the study and require a redo surgery will also be eligible for inclusion in a different part or step of the study.
Threshold current will be defined as the minimum current to elicit MEP responses with an amplitude higher than 20 µV in at least 5 consecutive trials. The procedure will be to increase current until MEPs appear, then reduce current until they disappear, and then finely adjust current to the minimum for a consistent response.
Part 1: determination of the best stimulation circuit. Step 1 - comparison of 10-20 system stimulation circuits: Evaluation of 12 patients. Circuits of C1/C2, C3/C4, and C3 or C4/Cz-1cm for upper limb MEPs, and C1/C2, C3/C4, and Cz-1cm/Cz+6cm for lower limb MEPs. Acquisition of 12 MEPs per limb with each circuit.
Step 2 - comparison of the best Step 1 circuit to the neuronavigation-guided stimulation circuit: Evaluation of 16 patients. Acquisition of 22 upper limb MEPs with each circuit.
Part 2: determination of the best stimulation parameters. Step 1 - comparison of different pulse durations: Evaluation of 21 patients. Pulse duration of 100, 200, 350, 500, 650, 800, and 1000 µs. Acquisition of 21 upper limb MEPs with each pulse duration.
Step 2 - comparison of different ISIs: Evaluation of 30 patients (15 per limb). ISI of 1, 2, 3, 4, and 5 ms. Acquisition of 20 upper and lower limb MEPs with each ISI.
Step 3 - comparison of different numbers of pulses: Evaluation of 15 patients. Number of pulses of 3, 4, 5, 7, and 9. Acquisition of 20 upper limb MEPs with each number of pulses.
Step 4 - comparison of single train to double-train facilitation at different inter train intervals (ITIs): Evaluation of 21 patients. Single train, double train (2/7 and 4/4 pulses). ITI of 20, 85, and 150 ms. Acquisition of 21 upper limb MEPs with each paradigm.
Step 5 - comparison of single train to multi-train facilitation at different rates: Evaluation of 21 patients. Single train at rate of 0.5 Hz. Multi-train facilitation at rates of 1, 2, 3, 4, 5, and 6 Hz. Acquisition of 21 upper limb MEPs with each paradigm.
Part 3: determination of the best recording montages. Step 1 - comparison of recording electrode orientations: Evaluation of 12 patients. Recordings from extensor digitorum communis (EDC) and tibialis anterior (TA). Three recording orientations: 1) bipolar perpendicular to muscle fibres, 2) bipolar parallel to muscle fibres, and 3) referential to the distal muscle tendon. Determination of threshold* per orientation within each muscle.
Step 2 - determination of muscles of choice in distal upper limbs: Evaluation of 21 patients. Recordings from abductor pollicis brevis (APB), abductor digiti minimi (ADM), first dorsal interosseous, EDC, flexor carpi radialis (FCR), APB/ADM, and EDC/FCR. Determination of threshold* for all muscles.
Step 3 - determination of muscles of choice in distal lower limbs: Evaluation of 18 patients. Recordings from abductor hallucis (AH), extensor digitorum brevis (EDB), TA, soleus, AH/EDB, and TA/soleus. Determination of threshold* for all muscles.
Part 4: Evaluation of 16 patients. Comparison of best stimulation and recording methodology from the results of Parts 1 to 3 with the current standard in our department. Acquisition of 22 MEPs per limb by paradigm.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Study Arm | Experimental | Device: ISIS IOM SystemApplication of TES at different stimulation circuits, with different stimulation parameters and recording montages. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Informed consent signed by the subject
- The patient has a supra-tentorial lesion requiring surgery
- The patient is undergoing neurosurgery with the use of MEP monitoring during surgery to protect functional tissue* (During routine preparation for the surgery, patients are checked for any relative contraindications as listed in the user manual of the ISIS IOM System (see p. 11, chapter 2.2.4 of the user manual). Every relative contraindication must be weighed against the risk and benefits of the measurement signals which are routinely needed for the surgical intervention. There are no absolute contraindications for the ISIS IOM System.)
- The patient is older than 18 years
Key exclusion criteria (9 listed)
- No need for MEP monitoring
- Vulnerable subjects (pregnant, impaired consciousness)
- People who do not want to participate in the study
- Emergency procedures in which no consent was obtained before the operation
- Multiple surgeries on the same patient
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ISIS IOM SystemApplication of TES at different stimulation circuits, with different stimulation parameters and recording montages. | Device | Study Arm |
Primary outcome
threshold of stimulation and patient movement
Time frame: during surgery
threshold of stimulation and patient movement quantified by an accelerometer placed on the forehead of the patient
3 secondary outcomes
patient movement
Time frame: during surgery
subjective evaluation of magnitude of motion
Time frame: end of surgery
quantification of magnitude
Time frame: end of surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2026.
- Background: PubMed 27481235Holdefer RN, Skinner SA. Commentary : The value of intraoperative neurophysiological monitoring: evidence, equipoise and outcomes. J Clin Monit Comput. 2017 Aug;31(4):657-664. doi: 10.1007/s10877-016-9910-0. Epub 2016 Aug 1.
- Background: PubMed 34199853Asimakidou E, Abut PA, Raabe A, Seidel K. Motor Evoked Potential Warning Criteria in Supratentorial Surgery: A Scoping Review. Cancers (Basel). 2021 Jun 4;13(11):2803. doi: 10.3390/cancers13112803.
- Background: PubMed 23198802Seidel K, Beck J, Stieglitz L, Schucht P, Raabe A. The warning-sign hierarchy between quantitative subcortical motor mapping and continuous motor evoked potential monitoring during resection of supratentorial brain tumors. J Neurosurg. 2013 Feb;118(2):287-96. doi: 10.3171/2012.10.JNS12895. Epub 2012 Nov 30.
- Background: PubMed 24055297Macdonald DB, Skinner S, Shils J, Yingling C; American Society of Neurophysiological Monitoring. Intraoperative motor evoked potential monitoring - a position statement by the American Society of Neurophysiological Monitoring. Clin Neurophysiol. 2013 Dec;124(12):2291-316. doi: 10.1016/j.clinph.2013.07.025. Epub 2013 Sep 18.
- Background: PubMed 36924672Dulfer SE, Gadella MC, Sahinovic MM, Lange F, Absalom AR, Groen RJM, Szelenyi A, Drost G. Stimulation parameters for motor evoked potentials during intraoperative spinal cord monitoring. A systematic review. Clin Neurophysiol. 2023 May;149:70-80. doi: 10.1016/j.clinph.2023.02.170. Epub 2023 Mar 4.
- Background: PubMed 25816090Fujii M, Maesawa S, Motomura K, Futamura M, Hayashi Y, Koba I, Wakabayashi T. Intraoperative subcortical mapping of a language-associated deep frontal tract connecting the superior frontal gyrus to Broca's area in the dominant hemisphere of patients with glioma. J Neurosurg. 2015 Jun;122(6):1390-6. doi: 10.3171/2014.10.JNS14945. Epub 2015 Mar 27.
- Background: PubMed 22848821Kapsalakis IZ, Kapsalaki EZ, Gotsis ED, Verganelakis D, Toulas P, Hadjigeorgiou G, Chung I, Fezoulidis I, Papadimitriou A, Robinson JS, Lee GP, Fountas KN. Preoperative evaluation with FMRI of patients with intracranial gliomas. Radiol Res Pract. 2012;2012:727810. doi: 10.1155/2012/727810. Epub 2012 Jul 12.
- Background: PubMed 30138733Moiyadi A, Velayutham P, Shetty P, Seidel K, Janu A, Madhugiri V, Singh VK, Patil A, John R. Combined Motor Evoked Potential Monitoring and Subcortical Dynamic Mapping in Motor Eloquent Tumors Allows Safer and Extended Resections. World Neurosurg. 2018 Dec;120:e259-e268. doi: 10.1016/j.wneu.2018.08.046. Epub 2018 Aug 21.
- Background: PubMed 24628613Raabe A, Beck J, Schucht P, Seidel K. Continuous dynamic mapping of the corticospinal tract during surgery of motor eloquent brain tumors: evaluation of a new method. J Neurosurg. 2014 May;120(5):1015-24. doi: 10.3171/2014.1.JNS13909. Epub 2014 Mar 14.
- Background: PubMed 25434385Schucht P, Seidel K, Beck J, Murek M, Jilch A, Wiest R, Fung C, Raabe A. Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome. Neurosurg Focus. 2014 Dec;37(6):E16. doi: 10.3171/2014.10.FOCUS14524.
- Individual participant dataSharing planned: No
Related trials for Surgery
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
RecruitingObservational study
Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider
Spinal (Fusion) Surgery, Total Intravenous Anesthesia
RecruitingPhase 1
Serial Amnioinfusions as Regenerative Therapy for Pulmonary Hypoplasia
Renal Failure Congenital, Congenital Renal Anomaly Nos
RecruitingPhase 2
Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial
Locally Advanced Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma
RecruitingPhase 2/3
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Pablo Abel Alvarez Abut, MD contact
Seidel Kathleen, MD principal investigator
Department of Neurosurgery
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ISIS IOM System in people with Surgery, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Seidel Kathleen, MD (+41 31 632 57 88, kathleen.seidel@insel.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
threshold of stimulation and patient movement (time frame: during surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06480370, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.